A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma

article

A RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41598-019-39273-4
P932PMC publication ID6385312
P698PubMed publication ID30796273

P2093author name stringLiping Wang
Xinhong Zhang
Shuguang Zuo
P2860cites workA scaling normalization method for differential expression analysis of RNA-seq dataQ24628783
Exciting new advances in neuro-oncology: the avenue to a cure for malignant gliomaQ24632791
An integrated genomic analysis of human glioblastoma multiformeQ24648860
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.Q27824850
edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataQ27860819
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastomaQ27860910
The somatic genomic landscape of glioblastomaQ28300185
CD79B and MYD88 mutations in diffuse large B-cell lymphomaQ51121788
Mining TCGA database for genes of prognostic value in glioblastoma microenvironment.Q54195728
ß-Elemene inhibits proliferation of human glioblastoma cells and causes cell-cycle G0/G1 arrest via mutually compensatory activation of MKK3 and MKK6.Q54398698
Transmission of a TP53 germline mutation from unaffected male carrier associated with pediatric glioblastoma in his child and gestational choriocarcinoma in his female partner.Q54942730
Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1.Q55154557
A Review of the Potential Utility of Mycophenolate Mofetil as a Cancer TherapeuticQ59051193
Therapeutic targeting of the BCR-associated protein CD79b in a TCR-based approach is hampered by aberrant expression of CD79bQ64166628
Ten-year survival in glioblastoma. A systematic reviewQ88866300
Characterization of human type I and type II IMP dehydrogenasesQ28623113
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaQ29615604
Survival in glioblastoma: a review on the impact of treatment modalities.Q30251810
Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patientsQ30458538
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger ageQ33378354
Performance status during and after radiotherapy plus concomitant and adjuvant temozolomide in elderly patients with glioblastoma multiformeQ33405266
Human cancers express mutator phenotypes: origin, consequences and targetingQ33554201
Treatment and outcomes for glioblastoma in elderly compared with non-elderly patients: a population-based studyQ33611190
Primary and secondary glioblastomas: from concept to clinical diagnosisQ34364235
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsQ34913026
Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin.Q35609699
Factors influencing survival in high-grade gliomasQ35650045
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomasQ36236484
Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications.Q36347205
Glioblastomas with copy number gains in EGFR and RNF139 show increased expressions of carbonic anhydrase genes transformed by ENO1.Q36713853
TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomesQ36777326
Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.Q37081252
Recent advances in p53 research: an interdisciplinary perspective.Q37273304
Comprehensive RNA-seq transcriptomic profiling in the malignant progression of gliomasQ37698352
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma-a critical review.Q37926494
Temozolomide and radiotherapy for newly diagnosed glioblastoma multiforme: a systematic reviewQ38170398
Comprehensive and Integrative Genomic Characterization of Hepatocellular CarcinomaQ38722204
Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.Q38731753
Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent mannerQ39090175
Assessment of the clinical relevance of 17q25.3 copy number and three-dimensional telomere organization in non-small lung cancer patientsQ40259346
MKK3 as oncotargetQ42583176
Analysis of chromosome 17 miRNAs and their importance in medulloblastomasQ43213773
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomasQ43276389
Radiotherapy for glioblastoma in the elderly.Q44527062
Impact of radiotherapy delay on survival in glioblastomaQ47312999
Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.Q47425171
Age alone is not a predictor for survival in glioblastoma.Q48626728
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P4510describes a project that usesedgeRQ113334690
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectglioblastomaQ282142
P304page(s)2615
P577publication date2019-02-22
P1433published inScientific ReportsQ2261792
P1476titleA RNA sequencing-based six-gene signature for survival prediction in patients with glioblastoma
P478volume9

Reverse relations

cites work (P2860)
Q92024236Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma
Q99546534Identification of a cullin5-RING E3 ligase transcriptome signature in glioblastoma multiforme
Q92798823Identification of seven-gene signature for prediction of lung squamous cell carcinoma
Q97568897Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis

Search more.